Prospective, Post-registration, Interventional, Randomized, in Parallel Groups, Multicenter Eurasian Clinical Study of DERIVO®/DERIVO® Mini Aneurysm Embolization Device, Europe-Asia
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 640 participants.
Also called NCT06400940
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 640 participants
- Sponsor
- Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
- Registry
-
NCT06400940
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Russia
- Registry status
- Recruiting
Technical summary
Registry record NCT06400940. Randomized; no masking; primary purpose treatment. Start 2023-08-17 (actual); primary completion 2026-08-17 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Prospective, Post-registration, Interventional, Randomized, in Parallel Groups, Multicenter Eurasian Clinical Study of DERIVO®/DERIVO® Mini Aneurysm Embolization Device, Europe-Asia
- Condition
- Intracranial Aneurysm
- Intervention (Drug)
- ticagrelor (tablets, 180 mg) or prasugrel (tablets, 10 mg).
- Intervention (Drug)
- combination of clopidogrel (tablets, 75 mg) and acetylsalicylic acid (ASA, tablets, 100 mg) or a combination of ticagrelor (tablets, 180 mg) and ASA (tablets, 100 mg).
- Lead sponsor
- Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
Record details
- Record id
cardio:ct-nct06400940- Content hash
d438b0a1c4c603b3d7ff4b1c8f9073b4d6ced5fc9f7a4bb43c1ad5d22786cc61